Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.10M | -52.40M | -47.25M | -34.82M | -58.52M |
| Total Depreciation and Amortization | 18.00K | 9.00K | 4.00K | 1.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.69M | 22.01M | 20.60M | 10.55M | 37.09M |
| Change in Net Operating Assets | 5.24M | 2.31M | 5.34M | 6.04M | 4.65M |
| Cash from Operations | -34.16M | -28.08M | -21.31M | -18.22M | -16.78M |
| Capital Expenditure | -117.00K | -75.00K | -30.00K | -17.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -5.00M | -5.00M | -7.25M | -13.00M |
| Cash from Investing | -117.00K | -5.08M | -5.03M | -7.27M | -13.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 73.54M | 68.16M | 68.16M | 62.42M | 63.95M |
| Repurchase of Common Stock | -318.00K | -318.00K | -- | -22.00K | -22.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 41.80M | 42.00M | 42.54M | 38.73M | 11.72M |
| Cash from Financing | 115.03M | 109.84M | 110.70M | 101.13M | 75.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.75M | 76.69M | 84.36M | 75.64M | 45.85M |